Menu

Investors

Abattis Bioceuticals is a public company traded on the CSE in Canada and through the OTC market in the United States.

Abattis Bioceuticals Corp. is a life sciences company which aggregates, integrates, and invests in biotechnology services internationally. The Company has successfully developed and licensed natural health products, medicines, extractions, and ingredients for the biological, nutraceutical, bioceutical, and cosmetic markets. The Company follows strict standard operating protocols and adheres to applicable laws of Canada and foreign jurisdictions.

Stock Exchanges and Trading:

OTC (United States): ATTBF
CSE (Canada): ATT

Latest Company filings can be found on SEDAR

SEC CIK:
0001515768
Fiscal Year End: 9/30
SIC – Industry Class: 2833 – medicinal and botanicals
Incorporated In: British Columbia, Canada
Year of Inc.: 1997

Officers

  • Robert Abenante – President & CEO
  • Francesco Paolini – CFO
  • Patrick Mitchell – COO

 

Directors

  • Robert Abenante – Director
  • Francesco Paolini – Director
  • Patrick Mitchell – Director
  • Cedric Wilson – Director

 

Auditors/Accounting

NVS Chartered Accountants Professional Corporation

 

Legal Counsel

Clark Wilson LLP

 

Transfer Agent

Computershare Investor Services Inc.